These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30647980)

  • 1. A Case of Myeloproliferative Neoplasm with BCR-FGFR1 Rearrangement: Favorable Outcome after Haploidentical Allogeneic Transplantation.
    Villafuerte-Gutiérrez P; López Rubio M; Herrera P; Arranz E
    Case Rep Hematol; 2018; 2018():5724960. PubMed ID: 30647980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic Hematopoietic Stem Cell Transplantation for a BCR-FGFR1 Myeloproliferative Neoplasm Presenting as Acute Lymphoblastic Leukemia.
    Haslam K; Langabeer SE; Kelly J; Coen N; O'Connell NM; Conneally E
    Case Rep Hematol; 2012; 2012():620967. PubMed ID: 23082258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8p11 Myeloproliferative syndrome with t(8;22)(p11;q11): A case report.
    Liu JJ; Meng L
    Exp Ther Med; 2018 Aug; 16(2):1449-1453. PubMed ID: 30116393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy.
    Li T; Zhang G; Zhang X; Lin H; Liu Q
    Front Oncol; 2022; 12():1015792. PubMed ID: 36408177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of a patient characterized by t(8;22)(p11;q11) and BCR/FGFR1 fusion gene, who was successfully treated with haploidentical hematopoietic stem cell transplantation.
    Chen X; Huang L; Zheng C; Wang Z
    Hematology; 2021 Dec; 26(1):691-696. PubMed ID: 34493159
    [No Abstract]   [Full Text] [Related]  

  • 7. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
    Landberg N; Dreimane A; Rissler M; Billström R; Ågerstam H
    Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
    Kumar KR; Chen W; Koduru PR; Luu HS
    Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement.
    Umino K; Fujiwara SI; Ikeda T; Toda Y; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Hematology; 2018 Sep; 23(8):470-477. PubMed ID: 29486661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis.
    Chen M; Wang K; Cai X; Zhang X; Chao H; Chen S; Shen H; Wang Q; Zhang R
    Hematology; 2021 Dec; 26(1):153-159. PubMed ID: 33491601
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical pathological features of the 8p11 myeloproliferative syndrome].
    Yan Z; Yang B; Wang QS; Wang LL; Han XP; Ren F; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1321-6. PubMed ID: 21129285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
    Morishige S; Oku E; Takata Y; Kimura Y; Arakawa F; Seki R; Imamura R; Osaki K; Hashiguchi M; Yakushiji K; Mizuno S; Yoshimoto K; Nagafuji K; Ohshima K; Okamura T
    Acta Haematol; 2013; 129(2):83-9. PubMed ID: 23171834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11;q11)/BCR-FGFR1 Rearrangement.
    Wang W; Tang G; Kadia T; Lu X; Li Y; Huang L; Montenegro-Garreaud X; Miranda RN; Wang SA
    J Natl Compr Canc Netw; 2016 Jun; 14(6):708-11. PubMed ID: 27283163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A rare case of myeloproliferative disease with t(8;13)(p11;q12) associated with eosinophilia and lymphadenopathy].
    Tsyba NN; Turkina AG; Chelysheva EY; Nemchenko IS; Kovrigina AM; Obukhova TN; Urnova ES; Kuzmina LA; Savchenko VG
    Ter Arkh; 2016; 88(7):98-103. PubMed ID: 27459622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring.
    Jabbour E; Kantarjian H
    Am J Hematol; 2020 Jun; 95(6):691-709. PubMed ID: 32239758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid/lymphoid neoplasms with FGFR1 rearrangement.
    Strati P; Tang G; Duose DY; Mallampati S; Luthra R; Patel KP; Hussaini M; Mirza AS; Komrokji RS; Oh S; Mascarenhas J; Najfeld V; Subbiah V; Kantarjian H; Garcia-Manero G; Verstovsek S; Daver N
    Leuk Lymphoma; 2018 Jul; 59(7):1672-1676. PubMed ID: 29119847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion.
    Dolan M; Cioc A; Cross NC; Neglia JP; Tolar J
    Pediatr Blood Cancer; 2012 Jul; 59(1):194-6. PubMed ID: 22106025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.
    Murati A; Arnoulet C; Lafage-Pochitaloff M; Adélaide J; Derré M; Slama B; Delaval B; Popovici C; Vey N; Xerri L; Mozziconacci MJ; Boulat O; Sainty D; Birnbaum D; Chaffanet M
    Int J Oncol; 2005 Jun; 26(6):1485-92. PubMed ID: 15870860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute leukemia showing t(8;22)(p11;q11), myelodysplasia, CD13/CD33/CD19 expression and immunoglobulin heavy chain gene rearrangement.
    Shimanuki M; Sonoki T; Hosoi H; Watanuki J; Murata S; Mushino T; Kuriyama K; Tamura S; Hatanaka K; Hanaoka N; Nakakuma H
    Acta Haematol; 2013; 129(4):238-42. PubMed ID: 23328683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.